TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:49 PM EDT

TAO Synergies (TAOX) Change in Cash (2019 - 2026)

TAO Synergies' (TAOX) quarterly Change in Cash came in at -$1.3 million in Q2 2026, down 175.56% on a YoY basis from $1.7 million in Q2 2025, and up 31.02% quarter-over-quarter from -$1.9 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Change in Cash (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Change in Cash for 8 consecutive years, with -$1.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Cash fell 175.56% year-over-year to -$1.3 million; the trailing twelve-month figure through Jun 2026 stood at -$12.0 million (down 13.15% YoY), and the FY2025 full-year result was -$12.2 million, down 10.48% from the prior year.
  • Change in Cash improved to -$1.3 million in Q2 2026 per TAOX's latest filing, from -$1.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $11.1 million in Q4 2022 and bottomed at -$12.9 million in Q3 2025.
  • Historically, Change in Cash has averaged -$1.8 million across 5 years, with a median of -$2.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Change in Cash sank 494.07% in 2022, then surged 305.74% in 2025.
  • Over 5 years, Change in Cash stood at $11.1 million in 2022, then slumped by 127.51% to -$3.1 million in 2023, then soared by 35.76% to -$2.0 million in 2024, then jumped by 305.74% to $4.1 million in 2025, then sank by 131.52% to -$1.3 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$1.3 million, -$1.9 million, and $4.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Amgen 211.40 Bn 197.42 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 181.20 Bn 178.03 Bn 6.22 Bn -4.45 Bn
3 Vertex Pharmaceuticals 132.13 Bn 124.28 Bn 2.84 Bn 649.20 Mn
4 Regeneron Pharmaceuticals 82.53 Bn 74.53 Bn 3.93 Bn -504.60 Mn
5 Argenx Se 61.72 Bn 56.54 Bn 1.37 Bn -
6 Moderna 54.67 Bn 49.53 Bn 52.00 Mn -185.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn -2.94 Mn
8 Biogen 31.29 Bn 30.00 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 30.03 Bn 30.03 Bn 1.16 Mn -170.44 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn - -1.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.28 Mn
Mar 31, 2026 -1.85 Mn
Dec 31, 2025 4.05 Mn
Sep 30, 2025 -12.92 Mn
Jun 30, 2025 -463,545.00
Mar 31, 2025 -2.82 Mn
Dec 31, 2024 -1.97 Mn
Sep 30, 2024 -5.35 Mn
Jun 30, 2024 -1.35 Mn
Mar 31, 2024 -2.33 Mn
Dec 31, 2023 -3.07 Mn
Sep 30, 2023 -1.17 Mn
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -1.70 Mn
Dec 31, 2022 11.14 Mn
Sep 30, 2022 -2.42 Mn
Jun 30, 2022 -2.53 Mn
Mar 31, 2022 -2.93 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 -407,441.00